631 results on '"Jürgenliemk-Schulz, Ina"'
Search Results
152. Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis
153. SP-0003 EMBR ACE experience
154. Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis
155. Response to Yuce Sari et al.
156. Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial
157. Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer:Implications for shared decision making
158. Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva:An efficacy study
159. Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making
160. Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis
161. Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study
162. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
163. Response to Yuce Sari et al.
164. Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer
165. Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network
166. Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity
167. Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers
168. Comparison of Library of Plans with two daily adaptive strategies for whole bladder radiotherapy
169. Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study
170. Progression-free survival in patients with Ga-68-PSMA-PET-directed SBRT for lymph node oligometastases
171. ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology
172. Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases
173. Online MRI guidance for healthy tissue sparing in patients with cervical cancer: An IMRT planning study
174. Motion and deformation of the target volumes during IMRT for cervical cancer: What margins do we need?
175. Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study
176. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
177. Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer
178. Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network
179. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment
180. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment
181. Treatment of stage III–IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2
182. Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases
183. Dosimetric feasibility of hypofractionation for SBRT treatment of lymph node oligometastases on the 1.5T MR-linac
184. Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
185. The Netherlands: University Medical Center, Utrecht
186. Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases
187. Evidence-Based Dose Planning Aims and Dose Prescription in Image-Guided Brachytherapy Combined With Radiochemotherapy in Locally Advanced Cervical Cancer
188. Implementing an online radiotherapy quality assurance programme with supporting continuous medical education – report from the EMBRACE-II evaluation of cervix cancer IMRT contouring
189. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment
190. Indocyanine green versus technetium‐99m with blue dye for sentinel lymph node detection in early‐stage cervical cancer: A systematic review and meta‐analysis.
191. Compliance to surgical and radiation treatment guidelines in relation to patient outcome in early stage endometrial cancer
192. Prevention of pterygium recurrence by postoperative single-dose β-irradiation: a prospective randomized clinical double-blind trial
193. Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac : Multi-fraction treatment of pelvic lymph node oligometastases
194. Individual lymph nodes: 'See it and Zap it'
195. Evaluation of plan adaptation strategies for stereotactic radiotherapy of lymph node oligometastases using online magnetic resonance image guidance
196. Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases
197. Adaptive radiotherapy: The Elekta Unity MR-linac concept
198. Cervical cancer apparent diffusion coefficient values during external beam radiotherapy
199. Progression-free survival in patients with 68Ga-PSMA-PET-directed SBRT for lymph node oligometastases.
200. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3) : final results of an international, open-label, multicentre, randomised, phase 3 trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.